Drug · DIN 02267667
RABAVERT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 14, 2021; first marketed May 16, 2005.
- Drug Identification Number (DIN)
- 02267667
- Company (DIN owner)
- Bavarian Nordic AsHellerup, --, Denmark
- Schedule
- Schedule d
- Dosage form
- Powder For Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Rabies, inactivated, whole virus J07BG01
- Class
- Human
- Record last updated
- July 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INACTIVATED RABIES VIRUS (FLURY LEP) | 2.5 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 7, 2021: NOC 24989New Drug Submission (NDS) · Change in product ownership
- December 16, 2015: NOC 17562New Drug Submission (NDS) · Transfer of drug identification number
- February 5, 2010: NOC 11011New Drug Submission (NDS) · Manufacturer name change
- November 23, 2006: NOC 8428New Drug Submission (NDS) · Manufacturer name change
- April 29, 2005: NOC 6631New Drug Submission (NDS)